Knowledge Centre

Join us to discover Innovate UK’s Innovation Exchange (iX); a national programme aimed at accelerating innovation by linking industry needs with pioneering solutions drawn from across industry sectors.

Bactobio is pioneering the discovery of novel antibiotics and fungicides by exploring the vast, uncharted world of uncultured microorganisms—bacteria that exist in soil but have never been studied in the lab.

Oxford-based Greywolf Therapeutics is developing new treatments for cancer patients who currently have limited immunotherapy options. With support from Innovate UK’s Biomedical Catalyst and Cancer Therapeutics programmes, the company is focusing on colorectal cancer, the UK’s fourth most common cancer and second leading cause of cancer-related death.

Sheffield-based MetalloBio, in partnership with the School of Science and Technology and Medical Technologies Innovation Facility at Nottingham Trent University (NTU), is developing a new class of antimicrobial agent using an innovative inorganic chemistry approach.

Oxford-based Ufonia, with support from the Innovate UK Biomedical Catalyst programme, is using AI to automate routine clinical consultations to make health and care accessible to everyone at any time.

Sheffield-based Rinri Therapeutics, supported by the Innovate UK Biomedical Catalyst, is developing a therapy to treat sensorineural hearing loss, which could reconnect millions of people worldwide with their families, friends and communities.

The mission of Oxford-based, Cancer Research UK spin-out, Infinitopes, is to prevent cancer deaths by tackling the leading cause: Metastases.

Theolytics has created an extensive proprietary library of oncolytic viruses (viruses that kill cancer cells) to harness their potential to safely target and destroy tumour cells while leaving healthy cells intact.

Join us to explore textile industry water consumption and discover innovative examples from Africa, Asia and the UK.